Downloads provided by UsageCounts
pmid: 15258618
handle: 11427/20662
Dyslipidaemia refers to the abnormal metabolism of lipids, as measured in the blood. Triglycerides (triacylglycerol) and total cholesterol (free and esterified cholesterol) are commonly implicated in hyperlipidaemias. These lipids are transported together with proteins as lipoproteins, which are named according to their ultracentrifugal properties: very low-density lipoprotein (VLDL), low-density lipoprotein (LDL), high-density lipoprotein (HDL) and chylomicrons. Dyslipoproteinaemia refers to abnormalities of the lipoproteins. Understanding metabolism at a molecular level has made it possible to better define dyslipidaemias, their prevalences and phenotypes as recently described in the South African context.
Hyperlipoproteinemia Type II, South Africa, Arteriosclerosis, Lipoproteins, Humans, Hyperlipidemias
Hyperlipoproteinemia Type II, South Africa, Arteriosclerosis, Lipoproteins, Humans, Hyperlipidemias
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
| views | 5 | |
| downloads | 10 |

Views provided by UsageCounts
Downloads provided by UsageCounts